Company Lookup
Download Demo

Market News

This Month News

This Month News

send to a friend by email

JPH records net income of $6.18 million at the end of 2017


According to the financial statements of Jerusalem Pharmaceuticals JPH for the year 2017, Net profit after tax of the period reached 6,186,852 USD Compared with Net profit after tax 3,050,959 USD for 2016, a net increase in profit of 102.78%.Total assets of the company reached 59,710,745 USD compared with total assets of 52,970,017 USD at the end of year 2016, a net increase of 12.73%.Total liabilities of the company reached 10,272,289 USD compared with total liabilities of 12,709,989 USD at the end of year 2016, a net decrease of 19.17%. Net ownership equity of the company reached 49,438,456 USD (Including Non-Controlling Interests of 825,910 USD) compared with total owner equity of 40,260,028 USD (Including Non-Controlling Interests of 526,771 USD) at the end of year 2016, a net increase of 22.80%.



RSR posts net income of JD0.31 million in 9M 2021

APC records net income of JD0.82 million in 9M 2021

ARAB posts net income of JD0.02 million in 9M 2021

Al-Quds Index in a narrow range amid an increase in 9M financial data disclosures anticipation

PHARMACARE recommends distributing 10% cash dividends for the year 2020

A transaction on the stocks of TRSUT raises the trading value in the PEX

Al-Quds Index rebounds upwards in the first week of October



Sahem Trading & Investments Company - PEX Member and licensed by PCMA
© All Rights Reserved 2013